Soberana

Cuba’s Soberana Vaccine Shows Efficacy Rate of 62%

Cuba’s Soberana vaccine candidate has demonstrated a 62% efficacy rate in a two-dose schedule, BioCubaFarma announced on Saturday. Results are…

4 years ago

Cuba’s Vaccine Progress

According to Cuban television reports on Cuba's vaccine progress, executives from the Center for Genetic Engineering and Biotechnology (CIGB) and…

4 years ago

Phase III Clinical Trials of Cuba’s Soberana 02 Vaccine Begin

Phase III clinical trials of Cuba’s Soberana 02 vaccine for COVID-19 from the Finlay Vaccine Institute will begin after receiving…

4 years ago

France’s AFD and the Finlay Institute: Cooperation in Vaccine Development

France's Agence Française de Développement (AFD) (French Development Agency) reported this week that France's Ambassador to Cuba, Patrice Paoli, met…

5 years ago